作者：
Cuiyun,Li [1]
;
Wei,Xiang [2]
;
Min,Wu [3]
;
Hong,Zhang [4]
;
Jianqiu,Cheng [5]
;
Tao,Yang [6]
;
Jiajia,Mai [7]
;
Xiumei,Chi [8]
;
Xiuzhu,Gao [9]
;
Yanhua,Ding [10]
;
Junqi,Niu [11]
作者单位：
Phase I Clinical Trial Unit, First Hospital, Jilin University, Changchun, China. Electronic address: lcy2442929@jlu.edu.cn.
[1]
Tonghua Anrate Biopharmaceuticals Co., Ltd., Tonghua, Jilin, 134100, China. Electronic address: xiang_wei@anrate.cn.
[2]
Phase I Clinical Trial Unit, First Hospital, Jilin University, Changchun, China. Electronic address: wumin1987@jlu.edu.cn.
[3]
Phase I Clinical Trial Unit, First Hospital, Jilin University, Changchun, China. Electronic address: zhanghong2015@jlu.edu.cn.
[4]
Tonghua Anrate Biopharmaceuticals Co., Ltd., Tonghua, Jilin, 134100, China. Electronic address: cheng_jianqiu@anrate.cn.
[5]
Tonghua Anrate Biopharmaceuticals Co., Ltd., Tonghua, Jilin, 134100, China. Electronic address: yang_tao@anrate.cn.
[6]
Phase I Clinical Trial Unit, First Hospital, Jilin University, Changchun, China. Electronic address: 2272135673@qq.com.
[7]
Phase I Clinical Trial Unit, First Hospital, Jilin University, Changchun, China. Electronic address: chixm@jlu.edu.cn.
[8]
Phase I Clinical Trial Unit, First Hospital, Jilin University, Changchun, China. Electronic address: xiuzhugao@jlu.edu.cn.
[9]
Phase I Clinical Trial Unit, First Hospital, Jilin University, Changchun, China. Electronic address: dingyanh@jlu.edu.cn.
[10]
Department of Hepatology, First Hospital, Jilin University, Changchun, 130021, Jilin, China. Electronic address: junqiniu@jlu.edu.cn.
[11]
DOI
10.1016/j.ejps.2021.105923
PMID
34229078
发布时间
2021-08-12
换一批
换一批
